Previous Article | Next Article ![]()
Journal of Virology, September 2009, p. 9611-9615, Vol. 83, No. 18
0022-538X/09/$08.00+0 doi:10.1128/JVI.00936-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Institute for Virology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany
Received 12 May 2009/ Accepted 19 June 2009
Cytomegaloviruses (CMVs) code for immunoevasins, glycoproteins that are specifically dedicated to interfere with the presentation of antigenic peptides to CD8 T cells. Nonetheless, the biological outcome is not an immune evasion of the virus, since CD8 T cells can control CMV infection even when immunoevasins are expressed. Here, we compare the processing of a protective and a nonprotective epitope derived from the same viral protein, the antiapoptotic protein M45 in the murine model. The data provide evidence to conclude that protection against CMVs critically depends on antigenic peptides generated in an amount sufficient to exhaust the inhibitory capacity of immunoevasins.
Published ahead of print on 4 June 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»